Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients.

Loic YsebaertThérèse Aurran-SchleinitzCaroline DartigeasMarie-Sarah DilhuydyPierre FeugierAnne-Sophie MichalletOlivier TournilhacJehan DupuisPierre SinetClaire AlbrechtFlorence Cymbalista

Published in: American journal of hematology (2017)

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
acute myeloid leukemia
prognostic factors
chronic lymphocytic leukemia
peritoneal dialysis
diffuse large b cell lymphoma